Comparison of exercise treadmill test, flow mediated dilatation, and inflammation in individuals with low risk of adverse cardiovascular events

1Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscl Throm Vas. 2003; 23:168-75.10.1161/01.ATV.0000051384.43104.FCBonettiPOLermanLOLermanA.Endothelial dysfunction: a marker of atherosclerotic riskArterioscl Throm Vas.20032316875Open DOISearch in Google Scholar

2Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol. 2002; 39:257-65.10.1016/S0735-1097(01)01746-611788217CorrettiMCAndersonTJBenjaminEJCelermajerDCharbonneauFCreagerMAGuidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial arteryJ Am Coll Cardiol.20023925765Open DOISearch in Google Scholar

3Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-26.988716410.1056/NEJM199901143400207RossR.Atherosclerosis: an inflammatory diseaseN Engl J Med.199934011526Search in Google Scholar

4Vita JA, Keaney Jr JF. Endothelial function: a barometer for cardiovascular risk? Circulation. 2002; 106:640-2.1216341910.1161/01.CIR.0000028581.07992.56VitaJAKeaney JrJF.Endothelial function: a barometer for cardiovascular risk?Circulation.20021066402Search in Google Scholar

5Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscl Throm Vas. 2003; 23:168-75.10.1161/01.ATV.0000051384.43104.FCBonettiPOLermanLOLermanA.Endothelial dysfunction: a marker of atherosclerotic riskArterioscl Throm Vas.20032316875Open DOISearch in Google Scholar

6Chang JA, Froelicher VF. Clinical and exercise test markers of prognosis in patients with stable coronary artery disease. Curr Probl Cardiol. 1994; 19:533-87.7813229ChangJAFroelicherVF.Clinical and exercise test markers of prognosis in patients with stable coronary artery diseaseCurr Probl Cardiol.1994195338710.1016/0146-2806(94)90010-8Search in Google Scholar

7Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101:1899-906.10.1161/01.CIR.101.16.189910779454SchachingerVBrittenMBZeiherAM.Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart diseaseCirculation.2000101189990610779454Open DOISearch in Google Scholar

8Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000; 101:948-54.1070415910.1161/01.CIR.101.9.948SuwaidiJAHamasakiSHiganoSTNishimuraRAHolmesDR JrLermanA.Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunctionCirculation.20001019485410704159Search in Google Scholar

9Anuurad E, Ozturk Z, Enkhmaa B, Pearson TA, Berglund L. Association of lipoprotein-associated phospholipase A₂ with coronary artery disease in African-Americans and Caucasians. J Clin Endocrinol Metab. 2010; 95:2376-83.2019470710.1210/jc.2009-2498AnuuradEOzturkZEnkhmaaBPearsonTABerglundL.Association of lipoprotein-associated phospholipase A₂ with coronary artery disease in African-Americans and CaucasiansJ Clin Endocrinol Metab.201095237683286955020194707Search in Google Scholar

10Ozturk ZG, Ekmekci H, Ekmekci OB, Atukeren P, Butun I, Gode S, el al. Nontraditional risk factors in carotid artery disease. Clin Appl Thromb Hemost. 2010; 16:554-8.10.1177/107602960935432820460338OzturkZGEkmekciHEkmekciOBAtukerenPButunIGodeSNontraditional risk factors in carotid artery diseaseClin Appl Thromb Hemost.201016554820460338Open DOISearch in Google Scholar

11Gungor Z, Anuurad E, Enkhmaa B, Zhang W, Kim K, Berglund L. ApoE4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. Atherosclerosis. 2012; 223:230-4.10.1016/j.atherosclerosis.2012.04.02122632920GungorZAnuuradEEnkhmaaBZhangWKimKBerglundL.ApoE4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular riskAtherosclerosis.20122232304Open DOISearch in Google Scholar

12Anuurad E, Tracy RP, Pearson TA, Beckett L, Berglund L. Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. Am J Cardiol. 2009; 103:523-7.1919551410.1016/j.amjcard.2008.10.016AnuuradETracyRPPearsonTABeckettLBerglundL.Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-AmericansAm J Cardiol.20091035237Search in Google Scholar

13Bilgen D, Sonmez H, Ekmekci H, Ulutin T, Ozturk Z, Kokoglu E, el al. The relationship of TFPI, Lp(a) and oxidized LDL antibody levels in patients with coronary artery disease. Clin Biochem. 2005; 38:92-6.1560732410.1016/j.clinbiochem.2004.09.011BilgenDSonmezHEkmekciHUlutinTOzturkZKokogluEThe relationship of TFPI, Lp(a) and oxidized LDL antibody levels in patients with coronary artery diseaseClin Biochem.200538926Search in Google Scholar

14Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Inter Med. 2009; 151:483-95.10.7326/0003-4819-151-7-200910060-00009BuckleyDIFuRFreemanMRogersKHelfandM.C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task ForceAnn Inter Med.200915148395Open DOISearch in Google Scholar

15Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Arterioscl Throm Vas. 2005; 25:923-31.10.1161/01.ATV.0000160551.21962.a7ZalewskiAMacpheeC.Role of lipoprotein-associated phospholipase A2 in atherosclerosisArterioscl Throm Vas.20052592331Open DOISearch in Google Scholar

16H kkinen T, Luoma JS, Hiltunen MO, Macphee CH, Milliner KJ, Patel L, el al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscl Throm Vas. 1999; 19:2909-17.10.1161/01.ATV.19.12.2909HkkinenTLuomaJSHiltunenMOMacpheeCHMillinerKJPatelLLipoprotein-associated phospholipase A₂, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesionsArterioscl Throm Vas.199919290917Open DOISearch in Google Scholar

17Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, Virmani R. Lipoprotein-associated phospholipase A₂ protein expression in the natural progression of human coronary atherosclerosis. Arterioscl Throm Vas. 2006; 26:2523-9.10.1161/01.ATV.0000244681.72738.bcKolodgieFDBurkeAPSkorijaKSLadichEKutysRMakuriaATVirmaniR.Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosisArterioscl Throm Vas.20062625239Open DOISearch in Google Scholar

18Kim JY, Hyun YJ, Jang Y, Lee BK, Chae JS, Kim SE, et al. Lipoprotein-associated phospholipase A₂ activity is associated with coronary artery disease and markers of oxidative stress: a case-control study. Am J Clin Nutr. 2008; 88:630-7.18779277KimJYHyunYJJangYLeeBKChaeJSKimSELipoprotein-associated phospholipase A₂ activity is associated with coronary artery disease and markers of oxidative stress: a case-control studyAm J Clin Nutr.200888630710.1093/ajcn/88.3.630Search in Google Scholar

19Davidson MH, Corson MA, Alberts MJ, Anderson JL, Gorelick PB, Jones PH, et al. Consensus panel recommendation for incorporating lipoproteinassociated phospholipase A₂ testing into cardiovascular disease risk assessment guidelines. Am J Cardiol. 2008; 101:51F-7.10.1016/j.amjcard.2008.04.019DavidsonMHCorsonMAAlbertsMJAndersonJLGorelickPBJonesPHConsensus panel recommendation for incorporating lipoproteinassociated phospholipase A₂ testing into cardiovascular disease risk assessment guidelinesAm J Cardiol.200810151F7Open DOISearch in Google Scholar

20Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973; 85:546-62.463200410.1016/0002-8703(73)90502-4BruceRAKusumiFHosmerD.Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular diseaseAm Heart J.19738554662Search in Google Scholar

21Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959; 234:1971-5.13672998WarrenL.The thiobarbituric acid assay of sialic acidsJ Biol Chem.19592341971510.1016/S0021-9258(18)69851-5Search in Google Scholar

22Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994; 24:1468-74.10.1016/0735-1097(94)90141-47930277CelermajerDSSorensenKEBullCRobinsonJDeanfieldJE.Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interactionJ Am Coll Cardiol.199424146874Open DOISearch in Google Scholar

23Celermajer DS, Sorensen KE, Georgakopoulos D. Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993; 88:2149-55.10.1161/01.CIR.88.5.21498222109CelermajerDSSorensenKEGeorgakopoulosD.BullCThomasORobinsonJCigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adultsCirculation.199388214955Open DOISearch in Google Scholar

24Celermajer DS, Sorensen KE, Gaoch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340:1111-5.10.1016/0140-6736(92)93147-F1359209CelermajerDSSorensenKEGaochVMSpiegelhalterDJMillerOISullivanIDNon-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisLancet.199234011115Open DOISearch in Google Scholar

25Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991; 325:849-53.10.1056/NEJM1991091932512041875969MarkDBShawLHarrellFE JrHlatkyMALeeKLBengtsonJRPrognostic value of a treadmill exercise score in outpatients with suspected coronary artery diseaseN Engl J Med.199132584953Open DOISearch in Google Scholar

26McNeer JF, Margolis JR, Lee KL, Kisslo JA, Peter RH, Kong Y, et al. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation. 1978; 57:64-70.10.1161/01.CIR.57.1.64618399McNeerJFMargolisJRLeeKLKissloJAPeterRHKongYThe role of the exercise test in the evaluation of patients for ischemic heart diseaseCirculation.1978576470Open DOISearch in Google Scholar

27Weiner DA. The diagnostic and prognostic significance of an asymptomatic positive exercise test. Circulation. 1987; 75:II20-1.3815782WeinerDA.The diagnostic and prognostic significance of an asymptomatic positive exercise testCirculation198775II201Search in Google Scholar

28Mark DB, Hlatky MA, Califf RM, Morris JJ Jr, Sisson SD, McCants CB, et al. Painless exercise ST deviation on the treadmill: long term prognosis. J Am Coll Cardiol. 1989; 14:885-92.10.1016/0735-1097(89)90459-22794272MarkDBHlatkyMACaliffRMMorrisJJ JrSissonSDMcCantsCBPainless exercise ST deviation on the treadmill: long term prognosisJ Am Coll Cardiol.19891488592Open DOISearch in Google Scholar

29Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease. Circulation. 2003; 108:2093-8.10.1161/01.CIR.0000095273.92468.D914530195BrevettiGSilvestroASchianoVChiarielloM.Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial diseaseCirculation.200310820938Open DOISearch in Google Scholar

30Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004; 109:2518-23.1513649810.1161/01.CIR.0000128208.22378.E3BugiardiniRManfriniOPizziCFontanaFMorgagniG.Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiogramsCirculation.2004109251823Search in Google Scholar

31Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003; 41:1769-75.1276766310.1016/S0735-1097(03)00333-4GokceNKeaneyJF JrHunterLMWatkinsMTNedeljkovicZSMenzoianJOPredictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular diseaseJ Am Coll Cardiol.200341176975Search in Google Scholar

32Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002; 105:1567-73.1192752410.1161/01.CIR.0000012543.55874.47GokceNKeaneyJF JrHunterLMWatkinsMTMenzoianJOVitaJA.Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective studyCirculation.2002105156773Search in Google Scholar

33Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 2009; 134: 52-8.10.1016/j.ijcard.2008.01.02118479768ShechterMIssacharAMaraiIKoren-MoragNFreinarkDShaharYLong-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart diseaseInt J Cardiol.2009134528Open DOISearch in Google Scholar

34Witte DR, Broekmans WM, Kardinaal AF, Klöpping-Ketelaars IA, van Poppel G, Bots ML, et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis. 2003; 170:147-53.1295769310.1016/S0021-9150(03)00253-3WitteDRBroekmansWMKardinaalAFKlöpping-KetelaarsIAvan PoppelGBotsMLSoluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each otherAtherosclerosis.200317014753Search in Google Scholar

35Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flowmediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009; 120:502-9. 10.1161/CIRCULATIONAHA.109.864801YeboahJFolsomARBurkeGLJohnsonCPolakJFPostWPredictive value of brachial flowmediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosisCirculation.20091205029274097519635967Open DOISearch in Google Scholar